GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB grew its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 150.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,278 shares of the company's stock after buying an additional 6,770 shares during the period. Wilmington Savings Fund Society FSB's holdings in GE HealthCare Technologies were worth $1,058,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. LGT Financial Advisors LLC increased its stake in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 251 shares during the period. Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies in the third quarter valued at about $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Finally, Elkhorn Partners Limited Partnership bought a new position in shares of GE HealthCare Technologies during the 2nd quarter valued at about $31,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Down 0.6 %

GE HealthCare Technologies stock traded down $0.53 during trading hours on Friday, reaching $81.10. The stock had a trading volume of 2,836,005 shares, compared to its average volume of 3,052,807. GE HealthCare Technologies Inc. has a 52 week low of $71.31 and a 52 week high of $94.55. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market cap of $37.05 billion, a price-to-earnings ratio of 22.28, a PEG ratio of 2.96 and a beta of 1.07. The business's 50 day moving average price is $85.84 and its 200-day moving average price is $83.74.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter in the prior year, the firm earned $0.99 earnings per share. GE HealthCare Technologies's revenue for the quarter was up .9% on a year-over-year basis. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a $0.035 dividend. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.17%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.85%.

Insider Buying and Selling

In other news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company's stock.

Analyst Ratings Changes

Several brokerages have issued reports on GEHC. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective for the company in a research note on Wednesday, September 18th. JPMorgan Chase & Co. initiated coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective for the company. Stifel Nicolaus increased their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a research note on Monday, September 30th. Finally, UBS Group lowered shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and dropped their price objective for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $95.46.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.